Clinical Trial Update: Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC [Phase 2]

View source ↗

Summary

A Phase II neoadjuvant trial evaluating dose-dense paclitaxel plus cisplatin for operable Stage II and IIA non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED